| 注册
首页|期刊导航|中国临床药理学与治疗学|蛋白激酶全抑制分析揭示KG-1细胞增殖的分子机制

蛋白激酶全抑制分析揭示KG-1细胞增殖的分子机制

段毓 徐凝馨 曹琼 杨恺 王金娟 刘思瑾 贾峰峰 刘建兵 李莉

中国临床药理学与治疗学2024,Vol.29Issue(6):621-628,8.
中国临床药理学与治疗学2024,Vol.29Issue(6):621-628,8.DOI:10.12092/j.issn.1009-2501.2024.06.003

蛋白激酶全抑制分析揭示KG-1细胞增殖的分子机制

Comprehensive protein kinase inhibition analysis reveals the molecu-lar mechanism of KG-1 proliferation

段毓 1徐凝馨 2曹琼 3杨恺 1王金娟 1刘思瑾 1贾峰峰 4刘建兵 1李莉1

作者信息

  • 1. 山西医科大学基础医学院医学细胞生物与遗传学教研室,太原 030001,山西
  • 2. 焦作市儿童医院,焦作 454100,河南
  • 3. 太原市中心医院,太原 030009,山西
  • 4. 太原技术转移促进中心,太原 030006,山西
  • 折叠

摘要

Abstract

AIM:To investigate the molecular mechanisms of KG-1 cell proliferation by profiling its responses to various protein kinase inhibitors.METHODS:CCK-8 assay,real time quantitative PCR(qRT-PCR)and Western-blot were used to detect the effect of various protein kinase inhibitors on KG-1 cell proliferation,the expression levels of mRNA and phosphorylation level of signaling pro-teins in the FGFR1 downstream pathways.RE-SULTS:NVP-BGJ398 and PD173074 effectively in-hibited the proliferation of KG-1 cells,indicative of a crucial role of FGFR downstream signaling.After treatment with FGFR inhibitors,the levels of p-FG-FR1OP2-FGFR1 and p-STAT5 decreased significantly(P<0.001),p-AKT decreased slightly(P<0.05),with-out affecting the p-ERK level(P>0.05).CONCLU-SION:FGFR1OP2-FGFR1 mainly acts on the down-stream STAT5 signaling pathway to promote cell proliferation.Comprehensive protein kinase inhibi-tion analysis is a reliable and direct approach to identify functional drivers of cancer cell prolifera-tion.

关键词

KG-1细胞/蛋白激酶抑制剂/FGFR1OP2-FGFR1融合基因/STAT5

Key words

KG-1 cell line/protein kinase inhibi-tors/FGFR1OP2-FGFR1fusion gene/STAT5

分类

医药卫生

引用本文复制引用

段毓,徐凝馨,曹琼,杨恺,王金娟,刘思瑾,贾峰峰,刘建兵,李莉..蛋白激酶全抑制分析揭示KG-1细胞增殖的分子机制[J].中国临床药理学与治疗学,2024,29(6):621-628,8.

基金项目

山西省留学归国留学生科研资助计划(2020-076) (2020-076)

山西省自然科学基金(自由探索类)(20210302123307) (自由探索类)

国家自然科学基金面上项目(82272622) (82272622)

中国临床药理学与治疗学

OA北大核心CSTPCD

1009-2501

访问量4
|
下载量0
段落导航相关论文